Skip to content

Skip to navigation

Skip to search

Australian Capital Territory Department of Health ACT Government Health Information

Page tools

You are here:

  1. Home /
  2. Publications /
  3. Reports
  4. /Analysis of the needs of injecting drug users in the ACT

Analysis of the needs of injecting drug users in the ACT

A model for a supervised injecting place (SIP) was developed for Civic in 1998-99 when this area was the centre of drug related activity in the ACT.

A site has been located for the SIP at the Moore Street health building but some members of the Supervised Drug Injection Trial Advisory Committee have expressed ongoing concerns regarding the site and the trials feasibility for Civic.

Final Report for ACT Health - James Bloggs, June 2003

A model for a supervised injecting place (SIP) was developed for Civic in 1998-99 when this area was the centre of drug related activity in the ACT. A site has been located for the SIP at the Moore Street health building but some members of the Supervised Drug Injection Trial Advisory Committee have expressed ongoing concerns regarding the site and the trials feasibility for Civic.

The Supervised Drug Injection Trial Advisory Committee is in the process of reviewing work carried out to implement a Supervised Injecting Place (SIP) and is considering options for progressing this project. After Committee members visited the medically supervised injecting centre (MSIC) operating in Sydney, concerns were raised regarding the trials feasibility for Civic. ACT Health decided that it was timely to conduct an analysis of the needs of IDUs in the current injecting drug context of the ACT.

Download: Analysis of IDU needs in the ACT - Final Report June 2003 (Microsoft Word Document - 127k)

Summary/Abstract

The report, produced by Dr James Blogg, finds that injecting drug users would attend a supervised injecting place if a trial were to proceed in the ACT. It also points out that many injecting drug users who currently inject at home would attend a Supervised Injecting Place Trial.

Dr Blogg interviewed injecting drug users about three main issues:

- the priority they would place on the development of a Supervised Injecting Place Trial;

- whether injecting drug users would access a Supervised Injecting Place Trial at the Moore Street health building, and;

- whether a stand-alone or co-located model would be the most appropriate.

Dr Blogg also identified a number of other options that are available to support the needs of injecting drug users.

These include:
- installing vending machines to provide after hours access to needles and syringes;
- establishing a low threshold methadone program targeting young Indigenous people;
- a peer based naloxone distribution trial;
- a hydromorphone trial, and;
- substitution therapy for amphetamine users.

Back to top